Non-U.S. pharmaceuticals Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
01:51
Jan 28
Jan 28
Non-U.S. pharma offers attractive value.
Non-U.S. pharmaceuticals, especially in Switzerland and the UK, are strong businesses selling at attractive valuations. AstraZeneca, Roche, and Novartis are named as good-value examples.
MED
About Non-U.S. pharmaceuticals Investor Commentary
Across the available history and selected sources, Buzzberg tracks Non-U.S. pharmaceuticals across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: David Herro.